Firms abandoning antibiotics research
Drugs that make more money sought
America's drug industry, including anti-infection pioneers Eli Lilly & Co. and Wyeth, is abandoning research into antibiotics in favor of more lucrative drugs at a time when patients need new versions to fight drug-resistant bacteria. (Full Article: 911 Words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 Article
- $9.95 4 Articles
- $99.95 Unlimited
